These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103 related articles for article (PubMed ID: 11795260)
21. Collagens in the progression and complications of atherosclerosis. Adiguzel E; Ahmad PJ; Franco C; Bendeck MP Vasc Med; 2009 Feb; 14(1):73-89. PubMed ID: 19144782 [TBL] [Abstract][Full Text] [Related]
22. Matrix metalloproteinases in atherothrombosis. Bäck M; Ketelhuth DF; Agewall S Prog Cardiovasc Dis; 2010; 52(5):410-28. PubMed ID: 20226959 [TBL] [Abstract][Full Text] [Related]
23. The role of proteinases in angiogenesis, heart development, restenosis, atherosclerosis, myocardial ischemia, and stroke: insights from genetic studies. Luttun A; Dewerchin M; Collen D; Carmeliet P Curr Atheroscler Rep; 2000 Sep; 2(5):407-16. PubMed ID: 11122772 [TBL] [Abstract][Full Text] [Related]
25. Genes involved in atherosclerosis. Laukkanen J; Ylä-Herttuala S Exp Nephrol; 2002; 10(2):150-63. PubMed ID: 11937762 [TBL] [Abstract][Full Text] [Related]
26. Vascular extracellular matrix in atherosclerosis. Chistiakov DA; Sobenin IA; Orekhov AN Cardiol Rev; 2013; 21(6):270-88. PubMed ID: 23422022 [TBL] [Abstract][Full Text] [Related]
27. Coexpression of cyclooxygenase-2 and matrix metalloproteinases in human aortic atherosclerotic lesions. Hong BK; Kwon HM; Lee BK; Kim D; Kim IJ; Kang SM; Jang Y; Cho SH; Kim HK; Jang BC; Cho SY; Kim HS; Kim MS; Kwon HC; Lee N Yonsei Med J; 2000 Feb; 41(1):82-8. PubMed ID: 10731924 [TBL] [Abstract][Full Text] [Related]
28. Matrix metalloproteinases: their biological functions and clinical implications. Hijova E Bratisl Lek Listy; 2005; 106(3):127-32. PubMed ID: 16026148 [TBL] [Abstract][Full Text] [Related]
29. Expression of matrix metalloproteinases-1, -2, and -9; tissue inhibitors of matrix metalloproteinases-1 and -2; cathepsin B; urokinase plasminogen activator; and plasminogen activator inhibitor, type I in skull base chordoma. Naka T; Kuester D; Boltze C; Schulz TO; Samii A; Herold C; Ostertag H; Roessner A Hum Pathol; 2008 Feb; 39(2):217-23. PubMed ID: 17949787 [TBL] [Abstract][Full Text] [Related]
30. Involvement of the mural thrombus as a site of protease release and activation in human aortic aneurysms. Fontaine V; Jacob MP; Houard X; Rossignol P; Plissonnier D; Angles-Cano E; Michel JB Am J Pathol; 2002 Nov; 161(5):1701-10. PubMed ID: 12414517 [TBL] [Abstract][Full Text] [Related]
31. Preclinical Evaluation of RYM1, a Matrix Metalloproteinase-Targeted Tracer for Imaging Aneurysm. Toczek J; Ye Y; Gona K; Kim HY; Han J; Razavian M; Golestani R; Zhang J; Wu TL; Jung JJ; Sadeghi MM J Nucl Med; 2017 Aug; 58(8):1318-1323. PubMed ID: 28360209 [TBL] [Abstract][Full Text] [Related]
32. Genetic diversity in the matrix metalloproteinase family. Effects on function and disease progression. Henney AM; Ye S; Zhang B; Jormsjö S; Whatling C; Eriksson P; Hamsten A Ann N Y Acad Sci; 2000 May; 902():27-37; discussion 37-8. PubMed ID: 10865823 [TBL] [Abstract][Full Text] [Related]
33. Temporal and quantitative analysis of expression of metalloproteinases (MMPs) and their endogenous inhibitors in atherosclerotic lesions. Yu Y; Koike T; Kitajima S; Liu E; Morimoto M; Shiomi M; Hatakeyama K; Asada Y; Wang KY; Sasaguri Y; Watanabe T; Fan J Histol Histopathol; 2008 Dec; 23(12):1503-16. PubMed ID: 18830936 [TBL] [Abstract][Full Text] [Related]
34. Dual role of matrix metalloproteinases (matrixins) in intimal thickening and atherosclerotic plaque rupture. Newby AC Physiol Rev; 2005 Jan; 85(1):1-31. PubMed ID: 15618476 [TBL] [Abstract][Full Text] [Related]
35. Inhibiting extracellular matrix metalloproteinase inducer maybe beneficial for diminishing the atherosclerotic plaque instability. Xie S; Nie R; Wang J J Postgrad Med; 2009; 55(4):284-6. PubMed ID: 20083879 [TBL] [Abstract][Full Text] [Related]
36. Plasminogen and matrix metalloproteinase activation by enzymatically modified low density lipoproteins in monocytes and smooth muscle cells. May AE; Schmidt R; Bülbül BO; Hölderle M; Walther F; Schömig A; Gawaz M; Klouche M Thromb Haemost; 2005 Apr; 93(4):710-5. PubMed ID: 15841317 [TBL] [Abstract][Full Text] [Related]
37. Differential effects of doxycycline, a broad-spectrum matrix metalloproteinase inhibitor, on angiotensin II-induced atherosclerosis and abdominal aortic aneurysms. Manning MW; Cassis LA; Daugherty A Arterioscler Thromb Vasc Biol; 2003 Mar; 23(3):483-8. PubMed ID: 12615694 [TBL] [Abstract][Full Text] [Related]